{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T03:38:47Z","timestamp":1768016327977,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T00:00:00Z","timestamp":1360800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s00432-013-1391-7","type":"journal-article","created":{"date-parts":[[2013,2,13]],"date-time":"2013-02-13T05:04:38Z","timestamp":1360731878000},"page":"837-843","source":"Crossref","is-referenced-by-count":11,"title":["Insulin-like growth factor 1 and musculoskeletal pain among breast cancer patients on aromatase inhibitor therapy and women without a history of cancer"],"prefix":"10.1007","volume":"139","author":[{"given":"Lisa","family":"Gallicchio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy J.","family":"Helzlsouer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,14]]},"reference":[{"key":"1391_CR1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0960-0760(97)00120-9","volume":"63","author":"E Bajetta","year":"1997","unstructured":"Bajetta E, Ferrari L, Celio L, Mariani L, Miceli R, Di Leo A et al (1997) The aromatase inhibitor letrozole in advanced breast cancer: effects on serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels. J Steroid Biochem Mol Biol 63:261\u2013267","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1391_CR2","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1210\/jc.81.8.2848","volume":"81","author":"MF Bellantoni","year":"1996","unstructured":"Bellantoni MF, Vittone J, Campfield AT, Bass KM, Harman SM, Blackman MR (1996) Effects of oral versus transdermal estrogen on the growth hormone\/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study. J Clin Endocrinol Metab 81:2848\u20132853","journal-title":"J Clin Endocrinol Metab"},{"key":"1391_CR3","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1001\/jama.288.18.2282","volume":"288","author":"MR Blackman","year":"2002","unstructured":"Blackman MR, Sorkin JD, Munzer T, Bellantoni MF, Busby-Whitehead J, Stevens TE et al (2002) Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA 288:2282\u20132292","journal-title":"JAMA"},{"key":"1391_CR4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10549-009-0662-0","volume":"120","author":"T Cigler","year":"2010","unstructured":"Cigler T, Tu D, Yaffe MJ, Findlay B, Verma S, Johnston D, Richardson H, Hu H, Qi S, Goss PE (2010) A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women. Breast Cancer Res Treat 120:427\u2013435","journal-title":"Breast Cancer Res Treat"},{"key":"1391_CR5","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1200\/JCO.2006.08.8617","volume":"25","author":"AS Coates","year":"2007","unstructured":"Coates AS, Keshaviah A, Thurlimann B, Mouridsen H, Mauriac L, Forbes JF et al (2007) Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1\u201398. J Clin Oncol 25:486\u2013492","journal-title":"J Clin Oncol"},{"key":"1391_CR6","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040331","volume":"350","author":"RC Coombes","year":"2004","unstructured":"Coombes RC, Hall E, Gibson LJ, Paridaens R, Jassem J, Delozier T et al (2004) A randomized trial of exemestane after 2\u20133\u00a0years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 350:1081\u20131092","journal-title":"N Engl J Med"},{"key":"1391_CR7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0140-6736(07)60200-1","volume":"369","author":"RC Coombes","year":"2007","unstructured":"Coombes RC, Kilburn LS, Snowdon CF, Paridaens R, Coleman RE, Jones SE et al (2007) Survival and safety of exemestane versus tamoxifen after 2\u20133\u00a0years\u2019 tamoxifen treatment (Intergroup exemestane study): a randomised controlled trial. Lancet 369:559\u2013570","journal-title":"Lancet"},{"key":"1391_CR8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1210\/edrv-14-1-20","volume":"14","author":"E Corpas","year":"1993","unstructured":"Corpas E, Harman SM, Blackman MR (1993) Human growth hormone and human aging. Endocr Rev 14:20\u201339","journal-title":"Endocr Rev"},{"key":"1391_CR9","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/jnci\/95.11.779","volume":"95","author":"A Decensi","year":"2003","unstructured":"Decensi A, Robertson C, Viale G, Pigatto F, Johansson H, Kisanga ER et al (2003) A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers. J Natl Cancer Inst 95:779\u2013790","journal-title":"J Natl Cancer Inst"},{"key":"1391_CR10","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"2005","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687\u20131717","journal-title":"Lancet"},{"key":"1391_CR11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0960-0760(02)00040-7","volume":"80","author":"L Ferrari","year":"2002","unstructured":"Ferrari L, Martinetti A, Zilembo N, Pozzi P, Buzzoni R, La Torre I et al (2002) Short-term effects of anastrozole treatment on insulin-like growth factor system in postmenopausal advanced breast cancer patients. J Steroid Biochem Mol Biol 80:411\u2013418","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1391_CR12","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1210\/jc.81.6.2216","volume":"81","author":"VJ Frost","year":"1996","unstructured":"Frost VJ, Helle SI, Lonning PE, van der Stappen JW, Holly JM (1996) Effects of treatment with megestrol acetate, aminoglutethimide, or formestane on insulin-like growth factor (IGF) I and II, IGF-binding proteins (IGFBPs), and IGFBP-3 protease status in patients with advanced breast cancer. J Clin Endocrinol Metab 81:2216\u20132221","journal-title":"J Clin Endocrinol Metab"},{"key":"1391_CR13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10549-007-9698-1","volume":"105","author":"PE Goss","year":"2007","unstructured":"Goss PE (2007) Letrozole in the extended adjuvant setting: MA.17. Breast Cancer Res Treat 105:45\u201353","journal-title":"Breast Cancer Res Treat"},{"key":"1391_CR14","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","volume":"364","author":"PE Goss","year":"2011","unstructured":"Goss PE, Ingle JN, Ales-Martinez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J et al (2011) Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med 364:2381\u20132391","journal-title":"N Engl J Med"},{"key":"1391_CR15","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1093\/annonc\/mds055","volume":"23","author":"P Hadji","year":"2012","unstructured":"Hadji P, Kieback DG, Tams J, Hasenburg A, Ziller M (2012) Correlation of treatment-emergent adverse events and clinical response to endocrine therapy in early breast cancer: a retrospective analysis of the German cohort of TEAM. Ann Oncol 23:2566\u20132572","journal-title":"Ann Oncol"},{"key":"1391_CR16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1365-2265.1996.8610870.x","volume":"45","author":"SI Helle","year":"1996","unstructured":"Helle SI, Omsjo IH, Hughes SC, Botta L, Huls G, Holly JM, Lonning PE (1996) Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study. Clin Endocrinol (Oxf) 45:727\u2013732","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1391_CR17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10549-011-1729-2","volume":"131","author":"KJ Helzlsouer","year":"2012","unstructured":"Helzlsouer KJ, Gallicchio L, MacDonald R, Wood B, Rushovich E (2012) A prospective study of aromatase inhibitor therapy, vitamin D, C-reactive protein and musculoskeletal symptoms. Breast Cancer Res Treat 131:277\u2013285","journal-title":"Breast Cancer Res Treat"},{"key":"1391_CR18","first-page":"1401","volume":"22","author":"NL Henry","year":"2008","unstructured":"Henry NL, Giles JT, Stearns V (2008) Aromatase inhibitor-associated musculoskeletal symptoms: etiology and strategies for management. Oncology (Williston Park) 22:1401\u20131408","journal-title":"Oncology (Williston Park)"},{"key":"1391_CR19","first-page":"862","volume":"11","author":"MD Holmes","year":"2002","unstructured":"Holmes MD, Pollak MN, Hankinson SE (2002) Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 11:862\u2013867","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1391_CR20","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.1158\/0008-5472.CAN-11-1080","volume":"71","author":"X Hou","year":"2011","unstructured":"Hou X, Huang F, Macedo LF, Harrington SC, Reeves KA, Greer A, Finckenstein FG, Brodie A, Gottardis MM, Carboni JM, Haluska P (2011) Dual IGF-1R\/InsR inhibitor BMS-754807 synergizes with hormonal agents in treatment of estrogen-dependent breast cancer. Cancer Res 71:7597\u20137607","journal-title":"Cancer Res"},{"key":"1391_CR21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(05)74803-0","volume":"365","author":"A Howell","year":"2005","unstructured":"Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF et al (2005) Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5\u00a0years\u2019 adjuvant treatment for breast cancer. Lancet 365:60\u201362","journal-title":"Lancet"},{"key":"1391_CR22","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1210\/jc.85.1.464","volume":"85","author":"YJ Janssen","year":"2000","unstructured":"Janssen YJ, Helmerhorst F, Frolich M, Roelfsema F (2000) A switch from oral (2\u00a0mg\/day) to transdermal (50\u00a0\u03bcg\/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency. J Clin Endocrinol Metab 85:464\u2013467","journal-title":"J Clin Endocrinol Metab"},{"key":"1391_CR23","first-page":"3","volume":"16","author":"JI Jones","year":"1995","unstructured":"Jones JI, Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3\u201334","journal-title":"Endocr Rev"},{"key":"1391_CR24","first-page":"2259","volume":"34","author":"M Laroche","year":"2007","unstructured":"Laroche M, Borg S, Lassoued S, De Lafontan B, Roche H (2007) Joint pain with aromatase inhibitors: abnormal frequency of Sjogren\u2019s syndrome. J Rheumatol 34:2259\u20132263","journal-title":"J Rheumatol"},{"key":"1391_CR25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0960-0760(92)90380-2","volume":"41","author":"EA Lien","year":"1992","unstructured":"Lien EA, Johannessen DC, Aakvaag A, Lonning PE (1992) Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-I levels in breast cancer patients. J Steroid Biochem Mol Biol 41:541\u2013543","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1391_CR26","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.steroids.2011.02.034","volume":"76","author":"A Lintermans","year":"2011","unstructured":"Lintermans A, Neven P (2011) Pharmacology of arthralgia with estrogen deprivation. Steroids 76:781\u2013785","journal-title":"Steroids"},{"key":"1391_CR27","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/annonc\/mdq699","volume":"22","author":"A Lintermans","year":"2011","unstructured":"Lintermans A, Van CB, Van HM, Pans S, Verhaeghe J, Westhovens R et al (2011) Aromatase inhibitor-induced loss of grip strength is body mass index dependent: hypothesis-generating findings for its pathogenesis. Ann Oncol 22:1763\u20131769","journal-title":"Ann Oncol"},{"key":"1391_CR28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/14656566.2012.651459","volume":"13","author":"JK Litton","year":"2012","unstructured":"Litton JK, Arun BK, Brown PH, Hortobagyi GN (2012) Aromatase inhibitors and breast cancer prevention. Expert Opin Pharmacother 13:325\u2013331","journal-title":"Expert Opin Pharmacother"},{"key":"1391_CR29","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3816\/CBC.2007.n.038","volume":"7","author":"CA Presant","year":"2007","unstructured":"Presant CA, Bosserman L, Young T, Vakil M, Horns R, Upadhyaya G, Ebrahimi B, Yeon C, Howard F (2007) Aromatase inhibitor-associated arthralgia and\/or bone pain: frequency and characterization in non-clinical trial patients. Clin Breast Cancer 7:775\u2013778","journal-title":"Clin Breast Cancer"},{"key":"1391_CR30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00042192-199805040-00006","volume":"5","author":"T Raudaskoski","year":"1998","unstructured":"Raudaskoski T, Knip M, Laatikainen T (1998) Plasma insulin-like growth factor-I and its binding proteins 1 and 3 during continuous nonoral and oral combined hormone replacement therapy. Menopause 5:217\u2013222","journal-title":"Menopause"},{"key":"1391_CR31","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10549-011-1849-8","volume":"131","author":"VK Shanmugam","year":"2012","unstructured":"Shanmugam VK, McCloskey J, Elston B, Allison SJ, Eng-Wong J (2012) The CIRAS study: a case control study to define the clinical, immunologic, and radiographic features of aromatase inhibitor-induced musculoskeletal symptoms. Breast Cancer Res Treat 131:699\u2013708","journal-title":"Breast Cancer Res Treat"},{"key":"1391_CR32","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1056\/NEJMoa052258","volume":"353","author":"B Thurlimann","year":"2005","unstructured":"Thurlimann B, Keshaviah A, Coates AS, Mouridsen H, Mauriac L, Forbes JF et al (2005) A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 353:2747\u20132757","journal-title":"N Engl J Med"},{"key":"1391_CR33","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10911-008-9104-6","volume":"13","author":"SJ Weroha","year":"2008","unstructured":"Weroha SJ, Haluska P (2008) IGF-1 receptor inhibitors in clinical trials\u2013early lessons. J Mammary Gland Biol Neoplasia 13:471\u2013483","journal-title":"J Mammary Gland Biol Neoplasia"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-013-1391-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-013-1391-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-013-1391-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:40:41Z","timestamp":1559068841000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-013-1391-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,14]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["1391"],"URL":"https:\/\/doi.org\/10.1007\/s00432-013-1391-7","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,14]]}}}